The team headed by Dr. Hagop M. Kantarjian, MD, has recommended the therapy after molecular and genetic laboratory testing and the results are expected after three weeks, when the team will decide on further treatment.
The medical costs will be covered by Sprem, the statement said.
Sprem went to the MD Anderson Cancer Center on August 23.